The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
The SurTract Syringe will be distributed across hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026.
The inaugural procedure was performed by William J. Berghoff, MD, at Parkview Orthopedic Hospital in Fort Wayne, Indiana, marking a major milestone in the system’s limited market release and the next evolution of personalized knee arthroplasty
Results confirm reproducibility and research readiness for islet isolation of Biorep’s next generation laboratory platform
The launch of the Instinct sensor expands Medtronic’s sensor portfolio, offering more choice alongside the recently launched Simplera Sync™ sensor and the Guardian™ 4 sensor—all part of a growing ecosystem designed to make diabetes care easier and more personalized
Effective January 1, 2026, the Vivistim® procedure is assigned to New Technology Ambulatory Payment Classification 1580, with an associated national average payment of approximately $45,000
“Smartee’s advanced manufacturing ecosystem is built to scale with our global business growth,” said Mr. Haoxue Pu, Chief Technology Engineer at Smartee.
“Our cutting-edge digital production model enables us to meet the growing demand for Smartee-branded products worldwide while maintaining the highest standards of precision and quality. Furthermore, our modular production lines enable rapid responsiveness to evolving market requirements.”